Jacobson Resonance Enterprises

Jacobson Resonance Enterprises is a medical technology company that developed a proprietary electromagnetic therapy known as Jacobson Resonance. The technology employs extremely low-frequency and low-intensity magnetic fields, specifically in the pico-Tesla range, intended to stimulate biological healing and regulate physiological functions. The company's primary device, the Jacobson Resonator, was targeted at treating chronic conditions such as Parkinson's disease, fibromyalgia, and osteoarthritis. Although the company was once publicly traded on the OTC market, it has since become largely inactive, with its clinical claims remaining controversial within the broader medical community.